The purpose of this study is to determine the attitudes of healthcare professionals towards CoronaVac and BioNTech vaccines applied in Turkey without the completion of phase 3 studies and to contribute to the policies that will be developed for the vaccine. The data in the study were collected between 01.03.2021 and 31.03.2021. The population consists of healthcare workers working in primary and secondary healthcare institutions in Samsun (N= 11.840). In determining the sample size, the unknown prevalence was taken as 50% and the margin of error as 3% by using the Open Epi Calculator program and it was determined as 979 with an error level of 0.05 and a power of 80%. Two forms were used for data collection namely Personal Introductory Information Form and Vaccination Attitude Scale. The data were evaluated with regression model and descriptive analysis such as number and percentage. The average age of the participants in the study was 38.33 ± 8.852, the average working year was 14.99 ± 8.920, 61.7%. 79% of the healthcare professionals were vaccinated for Covid 19, and all of them were vaccinated with CoronaVac vaccine. The vaccine acceptance average for CoronaVac vaccine is 3.81 ± 0.870, and the vaccine acceptance average for BioNTech vaccine is 3.76 ± 0.778. The attitude of those with more education and working years is better than others towards the BioNTech vaccine. An important finding of the study is that 79% of the healthcare workers in the research group were vaccinated; in other words, 21% of them corresponding to one out of five people were not vaccinated. The second important finding of the study is that those with higher education and more working years have a better attitude towards BioNTech vaccine than others.
"Objectives: Vaccination is one of the most effective scientific inventions to prevent infectious diseases worldwide. Despite the evidence on the efficacy of vaccinations, vaccine refusal still poses a threat for human health. This study aims, firstly, to detect the underlying reasons of vaccine hesitancy concerning the COVID-19 among medical students and healthcare professionals; and, secondly, to compare the results between the two groups. Methods: This is an online, ongoing cross-sectional quantitative study based on a scale validated in the socio-cultural context in Turkey. The sample consists of students of medicine at six years of education including preparatory class at a foundation university in Istanbul, as well as the healthcare professionals at the affiliated hospitals of the same university. Data will mainly be collected through the Scale of Vaccine Hesitancy (1) annexed with demographic and open-ended questions detecting opinions about vaccination. T-test and chi-square tests will be used for the analysis of scale scores and demographic questions respectively. The open-ended questions will provide deeper findings on the issue. Discussion and Conclusion: While COVID-19 pandemic remains a global challenge, vaccine roll-out seems to be the best response to combat the disease. However, reluctance in acceptance of vaccines among diverse populations creates a risk for herd immunity. Comparatively investigating the motives of vaccine hesitancy among health-related populations may help proposing social, ethical guidance for medical education and health policies. Source: Kilincarslan, M. et al (2020). Development of Valid and Reliable Scale of Vaccine Hesitancy in Turkish Language. Konuralp Tıp Dergisi, 12(3), 420-429 . "
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.